Epidemiology
A low- to intermediate-grade malignant vascular tumor that can be multifocal in bone. Its behavior is variable; the extent in bone and soft tissue determines whether surgery, radiotherapy, or systemic therapy predominates.
Basic features
It often causes pain and multiple lytic (bone-thinning) lesions and can be mistaken for metastasis or myeloma. The diagnosis is confirmed by the characteristic WWTR1-CAMTA1 fusion (or, less often, YAP1-TFE3), which avoids treating it as a metastasis from an unknown primary.
Usual treatment
Treatment combines local control, a systemic evaluation, and cancer therapies according to the extent of disease and which organs are involved.
Outcomes and prognosis
The course varies: some forms are indolent (slow-growing) while others progress, so it requires expert follow-up.
